Lv7
3230 积分 2022-08-26 加入
Effects of the number of alternatives in public good discrete choice experiments
18小时前
待确认
Pulmonologists’ Attitudes and Role in Precision Medicine Biomarker Testing for Non-Small Cell Lung Cancer
8天前
已完结
Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
8天前
已完结
Qualitative Approaches to Understanding Patient Preferences
9天前
已完结
Conjoint Analysis Applications in Health – How are Studies being Designed and Reported?
1个月前
已完结
Sample size requirements for stated choice experiments
1个月前
已完结
Multi-center observational study on the adherence, quality of life, and adverse events in lung cancer patients treated with tyrosine kinase inhibitors
1个月前
已完结
Patients' Preferences for Attributes of Molecular Targeting Therapies for Advanced Non-Small Cell Lung Cancer with EGFR Mutations in Japan-A Discrete-Choice Experiment
1个月前
已关闭
De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer
1个月前
已完结
Head-to-head comparison of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in advanced pancreatic cancer: a target trial emulation using real-world data
1个月前
已完结
皖公网安备34019202002308
